Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PEPTIDE HAVING OSTEOBLAST DIFFERENTIATION AND ANGIOGENESIS-PROMOTING ACTIVITY, AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2016/175532
Kind Code:
A1
Abstract:
The present invention relates to a protein effective for osteoblast differentiation and angiogenesis promotion and, more specifically, to a peptide and a use thereof, wherein the peptide comprises 15 amino acids which are synthesized on the basis of some sites of a stromal cell derived factor (SDF-1) delta representing angiogenesis-promoting activity and osteoblast differentiation or osteogenesis activity.

Inventors:
YOON TAEK RIM (KR)
KIM HYUNG KEUN (KR)
SEON JONG KEUN (KR)
KIM JI HYUN (KR)
KANG JU YEON (KR)
Application Number:
PCT/KR2016/004346
Publication Date:
November 03, 2016
Filing Date:
April 26, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NAT UNIV CHONNAM IND FOUND (KR)
CHONNAM NAT UNIV HOSPITAL (KR)
International Classes:
A61K38/10; C07K7/08; C07K14/51; C12N5/00
Foreign References:
US20140288010A12014-09-25
US20110020375A12011-01-27
US20110207166A12011-08-25
Other References:
MISHIMA, SEIJI ET AL.: "Effective Ex Vivo Expansion of Hematopoietic Stem Cells using Osteoblast-differentiated Mesenchymal Stem Cells is CXCL12 Dependent", EUROPEAN JOURNAL OF HAEMATOLOGY, vol. 84, no. 6, 2010, pages 538 - 546, XP055326592
LISIGNOLI, GINA ET AL.: "CXCL12 (SDF-1) and CXCL13 (BCA-1) Chemokines Significantly induce Proliferation and Collagen Type I Expression in Osteoblasts from Osteoarthritis Patients", JOURNAL OF CELLULAR PHYSIOLOGY, vol. 206, no. 1, 2006, pages 78 - 85, XP055326596
See also references of EP 3290435A4
Attorney, Agent or Firm:
IAM PATENT & LAW FIRM (KR)
특허법인 아이엠 (KR)
Download PDF: